Celsus.ai: Advanced AI-Powered Medical Imaging Analysis for Precision Diagnostics

Celsus.ai is a cutting-edge artificial intelligence platform developed by LLC "Medical Screening Systems" that delivers highly accurate, intelligent analysis and interpretation of medical images, including mammograms, chest x-rays, fluorography, chest CT scans, and brain computed tomography. Designed for healthcare professionals and institutions, it supports early detection of critical conditions such as breast cancer, lung cancer, COVID-19, and brain hemorrhages with diagnostic accuracy exceeding 95% in key applications. The system is seamlessly integrated into existing healthcare infrastructure via PACS, RIS, and HIS systems using HL7/FHIR protocols, and offers flexible deployment options including API, web browser access, desktop installation, and on-screen integration with imaging equipment. With proven performance in pilot programs across 13 Russian regions and real-world implementation in Uzbekistan and Pakistan, Celsus.ai has earned international recognition, including a CE Mark, a Russian medical device registration in the highest hazard class, and top honors at the BRICS Solutions Award and AWS AI Challenge. Its ability to detect subtle pathologies invisible to human radiologists, reduce analysis time by one-third, and enable remote and mobile diagnostics makes it a transformative tool in modern radiology.

Key Features:

• Mammogram Analysis: Detects and highlights 11 classes of findings, assesses breast tissue density per ACR guidelines, and assigns Bi-RADS categories with >90% accuracy.
• Chest Imaging Detection: Identifies 10 pathologies in chest CT scans and detects abnormalities in fluorography and chest x-rays with >95% accuracy.
• Brain Hemorrhage Detection: AI-powered analysis of brain CT scans to identify signs of hemorrhages.
• High-Speed Processing: Analyzes mammography studies (4 projections) in under 60 seconds; chest CT and fluorography scans in under 8 seconds.
• Post Hoc Analysis: Enables retrospective review and analysis of previously acquired x-ray data.
• Multi-Modal Integration: Fully compatible with PACS, RIS, HIS, and digital radiographic equipment.
• Flexible Deployment: Available via API, web browser, desktop installation, and direct integration with medical imaging hardware.
• Remote & Mobile Diagnostics: Supports telemedicine and mobile fluorography units for outreach and decentralized care.
• Batch Processing: Multithreading capability for efficient handling of large volumes of imaging studies.
• Histological Study Analysis: Recently released system version for AI-driven interpretation of histological data.
• Regulatory Compliance: Certified as a medical device in Russia (RZN 2021/14449, highest hazard class) and holds CE Mark (SK-CA-001/DVC-SK-21-06-000018).
• Data Security & Privacy: Adheres to strict legislative, organizational, and technical data protection standards; processes personal data with user consent.
• Research-Backed Innovation: Developed with grant support from Skolkovo Foundation and Mail.ru Cloud Solutions; involved in ongoing research on AI in rectal cancer diagnosis.
• Customization & Collaboration: Offers tailored solutions and actively pursues partnerships in AI-driven medical applications.

Pricing: Celsus.ai operates on a freemium model, offering free access for initial evaluation and pilot testing, with premium subscription tiers available for full-scale deployment and advanced features.

Conclusion: Celsus.ai stands at the forefront of AI in medical imaging, combining clinical accuracy, regulatory trust, and seamless integration to empower radiologists and healthcare systems worldwide with faster, more reliable diagnostics—making it an indispensable tool for modern medical screening and decision support.